Monday, April 16, 2001
Statins, or HMG Co-A reductase inhibitors, are widely prescribed to
lower cholesterol. Retrospective studies have shown patients given the compounds had a
decreased incidence of Alzheimer's disease (AD) later in their lives. Two studies reported
last week support the idea that these drugs may be useful to treat or prevent AD.
Andrx Corp. last week reported that hyperlipidemia patients given its
Avicor, an extended release tablet formulation of lovastatin, had diminished blood levels
of amyloid-beta, the peptides that are overproduced in patients with inherited AD